Minimal Invasive Carpal Tunnel Release With the Novel Device (Carpal tunnel)

Minimally Invasive Carpal Tunnel Decompression Using a Novel Ergonomic Releasing Instrument

This is a prospective, open-label, parallel-group, randomized controlled trial to evaluate the postoperative outcome after carpal tunnel release by using mini CTS releaser and open method with duration of 6 months estimated.

The study hypothesis is that mini CTS releaser can offer similar functional outcomes to the open approach and avoid the complications of the open surgery.

Study Overview

• Status: Completed
• Conditions: Carpal Tunnel Syndrome
• Intervention / Treatment: Procedure: Carpal tunnel release surgery

Detailed Description

The current study is the first clinical trial of carpal tunnel syndrome treated by using a device - novel mini CTS releaser. The functional outcome and objective outcome will be recorded to prove the hypothesis that mini CTS releaser can offer similar functional outcomes to the open approach and decrease the complication rate in comparison of the open surgery.

When patients visit, the research physician confirms whether the eligibility criteria are met, and the physician verbally explains the research theme, purpose, and method of execution. After the patient's consent, he should sign the subject consent.

At baseline recruitment, a standardized in-person interview will be conducted by trained and certified study personnel according to structured questionnaires to obtain information on socio-demographic characteristics, habits of tobacco and alcohol use, peripheral blood sample will be also collected from each participant. All of the operated patients underwent a complete personal medical history review, detailed physical examination, as well as routine hematological tests.

Patients will be randomized 1:1 to mini CTS releaser group or to open release group. There will be 35 individuals in each treatment arm. The planned follow-up time will be scheduled.

Safety outcomes including adverse events and changes around surgical wound and neurologic sign will be recorded. Patients will be carefully observed and if any abnormality is noted, appropriate measures will be instituted. The surgical materials used are all certified by the Ministry of Health and Welfare in Taiwan. The possible side effects, such as infections or inflammatory reactions that may occur after surgery, will be given antibiotics or other appropriate treatments in accordance with standard medical procedures.

Data of baseline characteristics will be described using means with standard deviations (SDs) or medians and interquartile ranges (IQRs), or both for continuous variables and using frequencies (percentages) for categorical variables. Mean morphological measures (and changes) will be computed as averages across participants within each treatment group. Between-group baseline comparisons will be based on 2 independent two sample t test or Wilcoxon Mann-Whitney test for quantitative variables, and chi-square test or Fisher's exact test for categorical variables. P values less than 0.05 will be adjusted for multiple comparisons using Bonferroni correction. All statistical analyses will be performed using SAS software Version 9.4 (SAS Institute Inc., Cary, North Carolina).

• Study Type: Interventional
• Enrollment (Actual): 41
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Taiwan
  • Kaohsiung, Taiwan
    • Kaohsiung Medical University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• 20 years of age and above.
• clinically symptomatic and electrophysiologically confirmed carpal tunnel syndrome.
• no response to conservative treatment.
• Signed Informed Consent and willing to comply with doctors and nurses' order.

Exclusion Criteria:

• Subjects with recurrent carpal tunnel syndrome
• Subjects with coexisting cervical radiculopathy
• Subjects treated with systemic immunosuppressive or glucocorticosteroids, except subjects taking occasional doses or doses less than 10mg prednisolone per day or equivalent.
• Diabetic patients with pre-OP HbA1c >7%
• Subject included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator
• Known allergy/hypersensitivity to any of the components included into the investigation.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Sham Comparator: open release; A prospective, open-label, parallel-group to evaluate the postoperative outcome after carpal tunnel release by using open carpal tunnel release method with duration of 6 months estimated.	Procedure: Carpal tunnel release surgery; Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks postoperatively
Experimental: mini CTS releaser; A prospective, open-label, parallel-group to evaluate the postoperative outcome after carpal tunnel release by using mini CTS releaser method with duration of 6 months estimated.	Procedure: Carpal tunnel release surgery; Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks postoperatively

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from preoperative BCTQ SSS at 4 Weeks	The Symptom Severity Scale (SSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) is an 11-question patient-administered survey that rates the severity of the patient's carpal tunnel syndrome-specific symptoms on a scale of 1 (no symptoms) to 5 (worst symptoms)	preoperative and 4 weeks after surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Operation time	Outcomes from both interventions will be measured with this symptom severity and functional status carpal tunnel specific scale.	operation day
Wound size	Outcomes from both interventions will be measured with this symptom severity and functional status carpal tunnel specific scale.	Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks after surgery
Grip/pinch strength	Outcomes from both interventions will be measured with this symptom severity and functional status carpal tunnel specific scale.	Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks after surgery
Pain Scores on the Visual Analog Scale	Is a subjective assessment of pain. The Visual Analogue Scale (VAS) consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The patient is asked to mark his pain level on the line between the two endpoints. The distance between 'no pain at all' and the mark then defines the subject's pain. [0 (no pain), 10 (worst pain)]	Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks after surgery
Time off work	Differences in time off work between both procedures measured in days.	24 weeks after surgery
Number of Participants with Adverse Events	Infection, secondary operation, scar hypertrophy, scar hyper-sensitivity, tenderness, and pillar pain	3 days, 2 weeks, 4 weeks and 24 weeks after surgery
two point discrimination test	Outcomes from both interventions will be measured with this symptom severity and functional status carpal tunnel specific scale.	Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks after surgery
BCTQ SSS	The Symptom Severity Scale (SSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) is an 11-question patient-administered survey that rates the severity of the patient's carpal tunnel syndrome-specific symptoms on a scale of 1 (no symptoms) to 5 (worst symptoms).	Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks after surgery

Collaborators and Investigators

• Sponsor: Kaohsiung Medical University

Study record dates

Study Major Dates

• Study Start (Actual): September 8, 2021
• Primary Completion (Actual): December 31, 2022
• Study Completion (Actual): December 31, 2022

Study Registration Dates

• First Submitted: September 8, 2021
• First Submitted That Met QC Criteria: October 2, 2021
• First Posted (Actual): October 5, 2021

Study Record Updates

• Last Update Posted (Estimate): May 4, 2023
• Last Update Submitted That Met QC Criteria: May 3, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Keywords: Carpal Tunnel Syndrome
• Additional Relevant MeSH Terms: Nervous System Diseases; Wounds and Injuries; Neuromuscular Diseases; Mononeuropathies; Peripheral Nervous System Diseases; Median Neuropathy; Nerve Compression Syndromes; Cumulative Trauma Disorders; Sprains and Strains; Carpal Tunnel Syndrome
• Other Study ID Numbers: CTS001

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No